Zobrazeno 1 - 10
of 12
pro vyhledávání: '"COX-inhibiting nitric oxide donor"'
Autor:
Carla Ghelardini, Antonio Giordani, Andrea Cappelli, Giovanna Poce, Mariangela Biava, Alma Martelli, Gianfranco Caselli, Maurizio Anzini, Sara Consalvi, L. Sautebin, A. Di Capua, Vincenzo Calderone, Maria Cristina Breschi, P. Patrignani, Lucio Claudio Rovati, Lara Testai
Publikováno v:
Pharmacological Research. 78:1-9
Selective cyclooxygenase 2 (COX2) inhibitors (COXIBs) are effective anti-inflammatory and analgesic drugs with improved gastrointestinal (GI) safety compared to nonselective nonsteroidal anti-inflammatory drugs known as traditional (tNSAIDs). However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec5e3c242dbe36bbe79dcefd10b40d8
https://doi.org/10.1016/j.phrs.2013.09.008
https://doi.org/10.1016/j.phrs.2013.09.008
Autor:
Coavoy-Sanchez, Silvia Abigail, da Costa Marques, Leonardo Andre, Costa, Soraia Katia Pereira, Muscara, Marcelo Nicolas
Publikováno v:
Antioxidants & Redox Signaling; Feb2024, Vol. 40 Issue 4/6, p272-291, 20p
Autor:
Martelli, A.1, Testai, L.1, Anzini, M.2, Cappelli, A.2, Di Capua, A.2, Biava, M.3, Poce, G.3, Consalvi, S.3, Giordani, A.4, Caselli, G.4, Rovati, L.4, Ghelardini, C.5, Patrignani, P.6, Sautebin, L.7, Breschi, M.C.1, Calderone, V.1 calderone@farm.unipi.it
Publikováno v:
Pharmacological Research. Dec2013, Vol. 78, p1-9. 9p.
Autor:
Verdecchia, Paolo, Angeli, Fabio, Mazzotta, Giovanni, Martire, Paola, Garofoli, Marta, Gentile, Giorgio, Reboldi, Gianpaolo
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease; Aug2010, Vol. 2 Issue 4, p229-240, 12p
Publikováno v:
Osteoporosis International; Apr2008 Supplement 1, Vol. 19, p5-27, 23p, 8 Charts, 2 Graphs
Autor:
Per Agvald, Bror Jonzon, Janet Hoogstraate, L. Christofer Adding, Lars I. Andersson, Lars E. Gustafsson
Publikováno v:
British Journal of Pharmacology. 145:679-687
1 AZD3582 [4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoate] is a COX-inhibiting nitric oxide donor that inhibits COX-1 and COX-2. It is as effective as naproxen in models of pain and inflammation, but causes less gastroduodenal damage. Nitr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5327aa3c765e1c7454108ceb90b8b575
https://doi.org/10.1038/sj.bjp.0706236
https://doi.org/10.1038/sj.bjp.0706236
Autor:
Martelli A; Dipartimento di Farmacia, Università di Pisa, Via Bonanno, 6, I-56126 Pisa, Italy., Testai L, Anzini M, Cappelli A, Di Capua A, Biava M, Poce G, Consalvi S, Giordani A, Caselli G, Rovati L, Ghelardini C, Patrignani P, Sautebin L, Breschi MC, Calderone V
Publikováno v:
Pharmacological research [Pharmacol Res] 2013 Dec; Vol. 78, pp. 1-9. Date of Electronic Publication: 2013 Sep 29.
Autor:
L Christofer, Adding, Per, Agvald, Lars I, Andersson, Bror, Jonzon, Janet, Hoogstraate, Lars E, Gustafsson
Publikováno v:
British journal of pharmacology. 145(5)
1. AZD3582 [4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoate] is a COX-inhibiting nitric oxide donor that inhibits COX-1 and COX-2. It is as effective as naproxen in models of pain and inflammation, but causes less gastroduodenal damage. Nit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8058c8cdfb4778a9edc58427da9c9a4a
https://pubmed.ncbi.nlm.nih.gov/15852032
https://pubmed.ncbi.nlm.nih.gov/15852032
This new volume, Nanomedicine for the Treatment of Disease: From Concept to Application, looks at the application of nanomedicines with a particular focus on their use in the treatment of diseases. The chapters in this volume, contributed by eminent
Autor:
Charlotte Allerton
This book presents a contemporary review of the field of Pain Therapeutics, including the historical medicines which still dominate standard of care treatments, as well as the new mechanisms and combinations/reformulations that have dominated the reg